JezK
Edit File: 1632935707.M295032P241733.mocha3025.mochahost.com,S=9527,W=9667
Return-Path: <bounces+13288428-34de-dr.sultan=jack.ngo@em3451.selectscience.com> Delivered-To: dr.sultan@jack.ngo Received: from mocha3025.mochahost.com by mocha3025.mochahost.com with LMTP id mNQzDxufVGFFsAMAaMJ/gg (envelope-from <bounces+13288428-34de-dr.sultan=jack.ngo@em3451.selectscience.com>) for <dr.sultan@jack.ngo>; Wed, 29 Sep 2021 13:15:07 -0400 Return-path: <bounces+13288428-34de-dr.sultan=jack.ngo@em3451.selectscience.com> Envelope-to: dr.sultan@jack.ngo Delivery-date: Wed, 29 Sep 2021 13:15:07 -0400 Received: from o1.ptr5290.selectscience.com ([167.89.92.117]:49689) by mocha3025.mochahost.com with esmtps (TLS1.2) tls TLS_ECDHE_RSA_WITH_AES_128_GCM_SHA256 (Exim 4.94.2) (envelope-from <bounces+13288428-34de-dr.sultan=jack.ngo@em3451.selectscience.com>) id 1mVdAg-0017FD-9l for dr.sultan@jack.ngo; Wed, 29 Sep 2021 13:15:06 -0400 DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=selectscience.com; h=mime-version:from:subject:content-type:content-transfer-encoding:to; s=s1; bh=lCxZ8WJ912r9GlhOzPSZV7pgdcY6rUSCF/+zrMzci84=; b=HmWQWYA+P5gEBbUT/rz7ZYakn/qkbkUtp/1B669cmZ4gE/A9/ljjqV3ZqhaD/TzVeAsO 2qmIWCxvGvED/i2IVlLeoV6Vqn/jjuUVKUt1P0K5U8WF937UdVW/aiZk84ZaN+M4cHe4Wf FXdHOj9frU6pX2/4BvCBIsk5JuvTJxacI0I2uZUQuF9gGNcn3T+PHfGbTZ0ZF+/eFvhexr S03NI/KvhPHT/t9RDHhSbekx3bXjzFeet8YAFZHLWxT4KbdIZADQzhE0Sw/cSzmRGQzfAP slWdtHuOvW9qeR4DBGM2no1zfjBW4kwWdAjcFfisPi/PdtECuDHdleuPYe+VHvgQ== Received: by filterdrecv-7b5d7dc7c5-4nwfk with SMTP id filterdrecv-7b5d7dc7c5-4nwfk-1-61549EF1-14 2021-09-29 17:14:25.288281094 +0000 UTC m=+1358186.171309094 Received: from SS-WEB01 (unknown) by geopod-ismtpd-6-1 (SG) with ESMTP id YkK_5M_NQzm2OVDlnFzVPA for <webinar@selectscience.com>; Wed, 29 Sep 2021 17:14:24.984 +0000 (UTC) MIME-Version: 1.0 From: Charlie Carter <webinar@selectscience.com> Date: Wed, 29 Sep 2021 17:14:25 +0000 (UTC) Subject: Last chance: Hear from the experts developing immune cell therapies Content-Type: text/html; charset=us-ascii Content-Transfer-Encoding: quoted-printable Message-ID: <YkK_5M_NQzm2OVDlnFzVPA@geopod-ismtpd-6-1> X-SG-EID: =?us-ascii?Q?aWD1EYVVAMUKgUgnBNhErXGaZDsv72s6nINH7cSMRWoYp38m=2F5cGuo8CQsU=2FHN?= =?us-ascii?Q?2cw3BVZqo3vJegO5SJsIzNphe4zJAERNbsN8yyj?= =?us-ascii?Q?EG9KHGOV200nYecTNJPzmstIwmH9NPokbO2k9Bn?= =?us-ascii?Q?boXiFaE7oCwtKstBUkw+p8REOwqu1ap2tehCoxP?= =?us-ascii?Q?CFtTA2iATRdlcnZwiCB1UeXHWCmLOPxj3GuYVzH?= =?us-ascii?Q?T=2FHg19jj5O8YlYwRFo7X6kSsrd0Q9mnO7vraWr?= To: dr.sultan@jack.ngo X-Entity-ID: LHjqSk4arHVPSAxn7el6bQ== <!--[if !mso 9]><!--><p><span style=3D"display:none !important; visibility:= hidden;opacity:0;color:transparent;height:0;width:0;">Register for this fre= e webinar  = ; </span></p> <div style=3D"display: none; max-height: 0p= x; overflow: hidden;"> ‌ ‌ ‌ ‌ = ;‌ ‌ ‌ ‌ ‌ ‌ &z= wnj; ‌ ‌ </div><!--<![endif]--><p><span style=3D"t= ext-align: left; color: rgb(0, 0, 0); font-family: Calibri, sans-serif; fon= t-size: 11pt;">Dear Colleague,<br /><br />Therapeutic developers are on the= pinnacle of revolutionizing cell therapies with cutting-edge technologies = for editing the genome. In this free webinar, Dr. John Lambourne will cover= the advantages inherent to base editing technology and the impact it could= have on the development of cell-based therapies. <br /><br /> <strong><u>= <a href=3D"http://www.selectscience.net/go/?itemID=3D79&itemTypeID=3D4= &linkID=3Dregnowtext&mailID=3D14831&email=3Ddr.sultan@jack.ngo&= amp;URL=3Dhttps%3A%2F%2Fwww.selectscience.net%2Fregister.aspx%3FitemID%3D16= 21%26itemTypeID%3D54%26referrer%3Dselectsciencepromo-3%26utm_source%3DMembe= rs%26utm_medium%3DWebinar-Email%26utm_campaign%3DSartorius-September-2021" = style=3D" font-family: Calibri, sans-serif; font-size: 11pt; color: black;"= target=3D"_blank">Base editing: Impact on cell therapy and how to access i= t</a></u></strong><br />Thursday, September 30, at 16:00 BST / 17:00 CEST /= 11:00 EDT / 08:00 PDT <br /><br /> <a href=3D"http://www.selectscience.ne= t/go/?itemID=3D79&itemTypeID=3D4&linkID=3Dregnowtext&mailID=3D1= 4831&email=3Ddr.sultan@jack.ngo&URL=3Dhttps%3A%2F%2Fwww.selectscien= ce.net%2Fregister.aspx%3FitemID%3D1621%26itemTypeID%3D54%26referrer%3Dselec= tsciencepromo-3%26utm_source%3DMembers%26utm_medium%3DWebinar-Email%26utm_c= ampaign%3DSartorius-September-2021" style=3D" font-family: Calibri, sans-se= rif; font-size: 11pt;" target=3D"_blank">This webinar</a> will address the = following:<br /> <ul><li><span style=3D"text-align: left; color: rgb(0, 0, = 0); font-family: Calibri, sans-serif; font-size: 11pt;">What is base editin= g?</span></li><li><span style=3D"text-align: left; color: rgb(0, 0, 0); fon= t-family: Calibri, sans-serif; font-size: 11pt;">How will base editing, as = well as other safe gene engineering technologies, impact the effectiveness = of cell-based therapies?</span></li><li><span style=3D"text-align: left; co= lor: rgb(0, 0, 0); font-family: Calibri, sans-serif; font-size: 11pt;">How = can base editing be accessed and introduced into cell-based therapy pipelin= es?</span></li> </ul> <p><span style=3D"text-align: left; color: rgb(0, = 0, 0); font-family: Calibri, sans-serif; font-size: 11pt;"><table><tbody><t= r><td style=3D"background-color: #36b156; padding: 10px 10px 10px 10px;"><s= pan style=3D"text-align: left; color: rgb(0, 0, 0); font-family: Calibri, s= ans-serif; font-size: 11pt;"><a href=3D"http://www.selectscience.net/go/?it= emID=3D79&itemTypeID=3D4&linkID=3Dctabutton&mailID=3D14831&= email=3Ddr.sultan@jack.ngo&URL=3Dhttps%3A%2F%2Fwww.selectscience.net%2F= register.aspx%3FitemID%3D1621%26itemTypeID%3D54%26referrer%3Dselectsciencep= romo-3%26utm_source%3DMembers%26utm_medium%3DWebinar-Email%26utm_campaign%3= DSartorius-September-2021" style=3D"text-decoration: none; color: #ffffff; = font-family: Arial;" target=3D"_blank"><strong>Register now »</strong= ></a></span></td></tr></tbody></table><br /><br /><span style=3D"text-align= : left; color: rgb(0, 0, 0); font-family: Calibri, sans-serif; font-size: 1= 1pt;"><strong>All webinar participants can request a certificate of attenda= nce, including a learning outcomes summary, for continuing education purpos= es - <a href=3D"http://www.selectscience.net/go/?itemID=3D79&itemType= ID=3D4&linkID=3Dregnowtext&mailID=3D14831&email=3Ddr.sultan@jac= k.ngo&URL=3Dhttps%3A%2F%2Fwww.selectscience.net%2Fregister.aspx%3FitemI= D%3D1621%26itemTypeID%3D54%26referrer%3Dselectsciencepromo-3%26utm_source%3= DMembers%26utm_medium%3DWebinar-Email%26utm_campaign%3DSartorius-September-= 2021" style=3D" font-family: Calibri, sans-serif; font-size: 11pt;" target= =3D"_blank">register now</a>.</strong></span><br /><br /> <span style=3D= "text-align: left; color: rgb(0, 0, 0); font-family: Calibri, sans-serif; f= ont-size: 11pt;"><span style=3D"text-align: left; color: rgb(0, 0, 0); font= -family: Calibri, sans-serif; font-size: 11pt;">Please feel free to forward= this email to any colleagues or friends that may be interested.</span><br = /><br /><span style=3D"text-align: left; color: rgb(0, 0, 0); font-family: = Calibri, sans-serif; font-size: 11pt;">Kind regards,<br /><br />Charlie Car= ter<br />Associate Editor<br /><strong>SelectScience® - <em>The Fastest= Way to Expert Opinion™</em> </strong><br /><br />e: <a href=3D"http:= //www.selectscience.net/go/?itemID=3D79&itemTypeID=3D4&linkID=3Dmai= lto&mailID=3D14831&email=3Ddr.sultan@jack.ngo&URL=3Dhttp%3A%2F%= 2Fwww%2Eselectscience%2Enet%2Fcontact%2Easpx%3FitemID%3D14831%26itemTypeID%= 3D22%26utm_source%3DMembers%26utm_medium%3DWebinar-Email%26utm_campaign%3DS= artorius-September-2021" target=3D"_blank">editor@selectscience.net</a><br = />t: +44 1225 874666<br />f: +44 1225 874123<br />w: <a href=3D"http://www.= selectscience.net/go/?itemID=3D79&itemTypeID=3D4&linkID=3Dwebsite&a= mp;mailID=3D14831&email=3Ddr.sultan@jack.ngo&URL=3Dhttp%3A%2F%2Fwww= .selectscience.net%2Findex.aspx%3Futm_source%3DMembers%26utm_medium%3DWebin= ar-Email%26utm_campaign%3DSartorius-September-2021" target=3D"_blank">http:= //www.selectscience.net</a><br />a: SelectScience Ltd, Science House, Churc= h Farm Business Park, Corston, Bath, BA2 9AP, UK</span><br /></span><br /><= br /><span style=3D"text-align: left; color: rgb(0, 0, 0); font-family: Cal= ibri; font-size: 8pt;">SelectScience® is a registered trademark. The co= ntent of this email may be privileged and is confidential. It may not be di= sclosed to or used by anyone other than the intended recipient(s), nor copi= ed in any way. If received in error, please advise the sender and delete it= from your system. SelectScience Limited, VAT registration 1: 713563055. Co= mpany registration 1: 3597730. Registered office: The Old Boardroom, Collet= t Road, Ware, Herts, SG12 7LR, UK<img border=3D"0" height=3D"1" src=3D"http= ://www.selectscience.net/trackOpenRate.aspx?mailID=3D14831&email=3Ddr.s= ultan@jack.ngo" width=3D"1" /></span><br /><br /><a href=3D"http://www.sele= ctscience.net/SSUserUnSubscription.aspx?mailID=3D14831&email=3Ddr.sulta= n@jack.ngo" style=3D"COLOR: #000000; font-family:Calibri, Arial, Sans-Serif= ; font-size:9pt" target=3D"_blank">Click here to unsubscribe</a></p>